Skip to main content
Top
Published in: Annals of Surgical Oncology 6/2012

01-06-2012 | Breast Oncology

Paget’s Disease as a Local Recurrence after Nipple-Sparing Mastectomy: Clinical Presentation, Treatment, Outcome, and Risk Factor Analysis

Authors: Visnu Lohsiriwat, Stefano Martella, Mario Rietjens, Edoardo Botteri, Nicole Rotmensz, Mauro Giuseppe Mastropasqua, Cristina Garusi, Francesca De Lorenzi, Andrea Manconi, Maria Sommario, Benedetta Barbieri, Maximiliano Cassilha, Ilaria Minotti, Jean Yves Petit

Published in: Annals of Surgical Oncology | Issue 6/2012

Login to get access

Abstract

Background

Paget’s disease is a rare clinical and histological type of local recurrence (LR) after breast cancer treatment both in case of conservative surgery or nipple-sparing mastectomy (NSM) with or without intraoperative radiation.

Methods

We performed an analysis of 861 NSM with electron beam intraoperative radiotherapy (ELIOT) patients treated at the European Institute of Oncology from 2002 to 2008, focused on Paget’s disease local recurrence.

Results

In 861 patients (713 invasive carcinoma and 148 intraepithelial neoplasia), there were 36 local recurrences (4.18%), and among these were 7 Paget’s disease local recurrences (0.8%). Median follow-up was 50 months. Four cases presented with nipple areola complex (NAC) erosions, two crusted lesions, and one ulcerated NAC. The average latency period from the NSM to Paget’s disease local recurrence is 32 months (range, 12–49). Complete NAC removal was performed in all seven recurrences. The average follow-up after NAC removal was 47.4 months (range, 20–78). We found neither locoregional relapse nor metastatic event in this group. All patients were alive without disease.

Conclusions

Paget’s disease local recurrence can be found in a significant proportion after NSM. Any suspicious lesion on NAC requires prompt pathological confirmation. Primary carcinoma with ductal intraepithelial neoplasia or invasive ductal carcinoma with extensive in situ component, negative hormonal receptor, high pathological grade, overexpression of HER2/neu, and “HER2 positive (nonluminal)” subtype tend to be significantly associated with more Paget’s disease local recurrence and should be followed carefully.
Literature
1.
go back to reference Paget J. On disease of the mammary areola preceding cancer of mammary gland. St Bartholomew’s Hosp Rep. 1874;10:87–9. Paget J. On disease of the mammary areola preceding cancer of mammary gland. St Bartholomew’s Hosp Rep. 1874;10:87–9.
2.
3.
go back to reference Fu W, Mittel VK, Young SC. Paget disease of the breast: analysis of 41 patients. Am J Clin Oncol. 2001;24:397–400.PubMedCrossRef Fu W, Mittel VK, Young SC. Paget disease of the breast: analysis of 41 patients. Am J Clin Oncol. 2001;24:397–400.PubMedCrossRef
4.
go back to reference Muir R. Pathogenesis of Paget’s disease of the nipple and associated lesions. Br J Surg. 1935;22:728–37.CrossRef Muir R. Pathogenesis of Paget’s disease of the nipple and associated lesions. Br J Surg. 1935;22:728–37.CrossRef
5.
go back to reference Inglis K. Paget’s disease of the nipple; with special reference to the changes in the ducts. Am J Pathol. 1946;22:1–33. Inglis K. Paget’s disease of the nipple; with special reference to the changes in the ducts. Am J Pathol. 1946;22:1–33.
6.
go back to reference Mendez-Fernandez MA, Henly WS, Geis RC, et al. Paget’s disease of the breast after subcutaneous mastectomy and reconstruction with a silicone prosthesis. Plast Reconstr Surg. 1980;65:683–5.PubMedCrossRef Mendez-Fernandez MA, Henly WS, Geis RC, et al. Paget’s disease of the breast after subcutaneous mastectomy and reconstruction with a silicone prosthesis. Plast Reconstr Surg. 1980;65:683–5.PubMedCrossRef
7.
go back to reference Shearman CP, Watts GT. Paget’s disease of the nipple after subcutaneous mastectomy for cancer with primary reconstruction. Ann R Coll Surg Engl. 1986;68:17–8.PubMed Shearman CP, Watts GT. Paget’s disease of the nipple after subcutaneous mastectomy for cancer with primary reconstruction. Ann R Coll Surg Engl. 1986;68:17–8.PubMed
8.
go back to reference Menzies D, Barr L, Ellis H. Paget’s disease of the nipple occurring after wide local excision and radiotherapy for carcinoma of the breast. Eur J Surg Oncol. 1989;15:271–3.PubMed Menzies D, Barr L, Ellis H. Paget’s disease of the nipple occurring after wide local excision and radiotherapy for carcinoma of the breast. Eur J Surg Oncol. 1989;15:271–3.PubMed
9.
go back to reference Schnitt SJ, Connolly JL, Recht A, et al. Breast relapse following primary radiation therapy for early breast cancer. II. Detection, pathologic features and prognostic significance. Int J Radiat Oncol Biol Phys. 1985;11:1277–84.PubMedCrossRef Schnitt SJ, Connolly JL, Recht A, et al. Breast relapse following primary radiation therapy for early breast cancer. II. Detection, pathologic features and prognostic significance. Int J Radiat Oncol Biol Phys. 1985;11:1277–84.PubMedCrossRef
10.
go back to reference Peterse JL, van Dongen JA, Bartelink H. Recurrence of breast carcinoma after breast conserving treatment. Eur J Surg Oncol. 1988;14:123–6.PubMed Peterse JL, van Dongen JA, Bartelink H. Recurrence of breast carcinoma after breast conserving treatment. Eur J Surg Oncol. 1988;14:123–6.PubMed
11.
go back to reference Plastaras JP, Harris EE, Solin LJ. Paget’s disease of the nipple as local recurrence after breast-conservation treatment for early-stage breast cancer. Clin Breast Cancer. 2005;6:349–53.PubMedCrossRef Plastaras JP, Harris EE, Solin LJ. Paget’s disease of the nipple as local recurrence after breast-conservation treatment for early-stage breast cancer. Clin Breast Cancer. 2005;6:349–53.PubMedCrossRef
12.
go back to reference Harness JK, Vetter TS, Salibian AH. Areola and nipple-areola-sparing mastectomy for breast cancer treatment and risk reduction: report of an initial experience in a community hospital setting. Ann Surg Oncol. 2011;18:917–22.PubMedCrossRef Harness JK, Vetter TS, Salibian AH. Areola and nipple-areola-sparing mastectomy for breast cancer treatment and risk reduction: report of an initial experience in a community hospital setting. Ann Surg Oncol. 2011;18:917–22.PubMedCrossRef
13.
go back to reference Petit JY, Veronesi U, Orecchia R, et al. Nipple sparing mastectomy with nipple areola intraoperative radiotherapy: one thousand and one cases of a five years experience at the European institute of oncology of Milan (EIO). Breast Cancer Res Treat. 2009;117:333–8.PubMedCrossRef Petit JY, Veronesi U, Orecchia R, et al. Nipple sparing mastectomy with nipple areola intraoperative radiotherapy: one thousand and one cases of a five years experience at the European institute of oncology of Milan (EIO). Breast Cancer Res Treat. 2009;117:333–8.PubMedCrossRef
14.
go back to reference Petit JY, Veronesi U, Orecchia R, et al. The nipple-sparing mastectomy: early results of a feasibility study of a new application of perioperative radiotherapy (ELIOT) in the treatment of breast cancer when mastectomy is indicated. Tumori. 2003;89:288–91.PubMed Petit JY, Veronesi U, Orecchia R, et al. The nipple-sparing mastectomy: early results of a feasibility study of a new application of perioperative radiotherapy (ELIOT) in the treatment of breast cancer when mastectomy is indicated. Tumori. 2003;89:288–91.PubMed
16.
go back to reference Didier F, Radice D, Gandini S, et al. Does nipple preservation in mastectomy improve satisfaction with cosmetic results, psychological adjustment, body image and sexuality? Breast Cancer Res Treat. 2009;118:623–33.PubMedCrossRef Didier F, Radice D, Gandini S, et al. Does nipple preservation in mastectomy improve satisfaction with cosmetic results, psychological adjustment, body image and sexuality? Breast Cancer Res Treat. 2009;118:623–33.PubMedCrossRef
17.
go back to reference Algaithy ZK, Petit JY, Lohsiriwat V, et al. Nipple sparing mastectomy: Can we predict the factors predisposing to necrosis? Eur J Surg Oncol. 2012;38(2):125–9.PubMed Algaithy ZK, Petit JY, Lohsiriwat V, et al. Nipple sparing mastectomy: Can we predict the factors predisposing to necrosis? Eur J Surg Oncol. 2012;38(2):125–9.PubMed
18.
go back to reference Petit JY, Veronesi U, Lohsiriwat V, et al. Nipple-sparing mastectomy—is it worth the risk? Nat Rev Clin Oncol. 2011;8(12):742–7.PubMedCrossRef Petit JY, Veronesi U, Lohsiriwat V, et al. Nipple-sparing mastectomy—is it worth the risk? Nat Rev Clin Oncol. 2011;8(12):742–7.PubMedCrossRef
19.
go back to reference Orecchia R, Ciocca M, Lazzari R, et al. Intraoperative radiation therapy with electrons (ELIOT) in early-stage breast cancer. Breast. 2003;12:483–90.PubMedCrossRef Orecchia R, Ciocca M, Lazzari R, et al. Intraoperative radiation therapy with electrons (ELIOT) in early-stage breast cancer. Breast. 2003;12:483–90.PubMedCrossRef
20.
go back to reference Jamali FR, Ricci A Jr, Deckers PJ. Paget’s disease of the nipple-areola complex. Surg Clin North Am. 1996;76:365–81.PubMedCrossRef Jamali FR, Ricci A Jr, Deckers PJ. Paget’s disease of the nipple-areola complex. Surg Clin North Am. 1996;76:365–81.PubMedCrossRef
21.
go back to reference Sukumvanich P, Bentrem DJ, Cody HS 3rd, et al. The role of sentinel lymph node biopsy in Paget’s disease of the breast. Ann Surg Oncol. 2007;14:1020–3.PubMedCrossRef Sukumvanich P, Bentrem DJ, Cody HS 3rd, et al. The role of sentinel lymph node biopsy in Paget’s disease of the breast. Ann Surg Oncol. 2007;14:1020–3.PubMedCrossRef
22.
go back to reference Laronga C, Hasson D, Hoover S, et al. Paget’s disease in the era of sentinel lymph node biopsy. Am J Surg. 2006;192:481–3.PubMedCrossRef Laronga C, Hasson D, Hoover S, et al. Paget’s disease in the era of sentinel lymph node biopsy. Am J Surg. 2006;192:481–3.PubMedCrossRef
23.
go back to reference Chen CY, Sun LM, Anderson BO. Paget disease of the breast: changing patterns of incidence, clinical presentation, and treatment in the U.S. Cancer. 2006;107:1448–58.PubMedCrossRef Chen CY, Sun LM, Anderson BO. Paget disease of the breast: changing patterns of incidence, clinical presentation, and treatment in the U.S. Cancer. 2006;107:1448–58.PubMedCrossRef
24.
go back to reference Caliskan M, Gatti G, Sosnovskikh I, et al. Paget’s disease of the breast: the experience of the European Institute of Oncology and review of the literature. Breast Cancer Res Treat. 2008;112:513–21.PubMedCrossRef Caliskan M, Gatti G, Sosnovskikh I, et al. Paget’s disease of the breast: the experience of the European Institute of Oncology and review of the literature. Breast Cancer Res Treat. 2008;112:513–21.PubMedCrossRef
25.
go back to reference Wolber RA, Dupuis BA, Wick MR. Expression of c-erbB-2 oncoprotein in mammary and extramammary Paget’s disease. Am J Clin Pathol. 1991;96:243–7.PubMed Wolber RA, Dupuis BA, Wick MR. Expression of c-erbB-2 oncoprotein in mammary and extramammary Paget’s disease. Am J Clin Pathol. 1991;96:243–7.PubMed
26.
go back to reference Lovekin C, Ellis IO, Locker A, et al. c-erbB-2 oncoprotein expression in primary and advanced breast cancer. Br J Cancer. 1991;63:439–43.PubMedCrossRef Lovekin C, Ellis IO, Locker A, et al. c-erbB-2 oncoprotein expression in primary and advanced breast cancer. Br J Cancer. 1991;63:439–43.PubMedCrossRef
27.
go back to reference Goldhirsch A, Wood WC, Coates AS, et al. Strategies for subtypes–dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol. 2011;22:1736–47.PubMedCrossRef Goldhirsch A, Wood WC, Coates AS, et al. Strategies for subtypes–dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol. 2011;22:1736–47.PubMedCrossRef
28.
go back to reference Fu W, Lobocki CA, Silberberg BK, et al. Molecular markers in Paget disease of the breast. J Surg Oncol. 2001;77:171–8.PubMedCrossRef Fu W, Lobocki CA, Silberberg BK, et al. Molecular markers in Paget disease of the breast. J Surg Oncol. 2001;77:171–8.PubMedCrossRef
Metadata
Title
Paget’s Disease as a Local Recurrence after Nipple-Sparing Mastectomy: Clinical Presentation, Treatment, Outcome, and Risk Factor Analysis
Authors
Visnu Lohsiriwat
Stefano Martella
Mario Rietjens
Edoardo Botteri
Nicole Rotmensz
Mauro Giuseppe Mastropasqua
Cristina Garusi
Francesca De Lorenzi
Andrea Manconi
Maria Sommario
Benedetta Barbieri
Maximiliano Cassilha
Ilaria Minotti
Jean Yves Petit
Publication date
01-06-2012
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 6/2012
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-012-2226-5

Other articles of this Issue 6/2012

Annals of Surgical Oncology 6/2012 Go to the issue